Ekso Bionics Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Note 6 - Revenue (Tables)

Note 6 - Revenue (Tables)

3 Months Ended

Mar. 31, 2024

Notes Tables

Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]

		*March 31, 2024*				*December 31, 2023*
Deferred extended maintenance and support		$	3,915				3,993
Deferred device and advances			232				169
Total deferred revenues			4,147				4,162
Less current portion			(2,028	)			(1,993	)
Deferred revenues, non-current		$	2,119			$	2,169

Beginning balance		$	4,162
Deferral of revenue			684
Recognition of deferred revenue			(699	)
Ending balance		$	4,147

Disaggregation of Revenue [Table Text Block]

		*EksoHealth*				*EksoWorks*				*Total*
Device revenue		$	2,585			$	168			$	2,753
Service and support			765				—				765
Subscriptions			144				—				144
Parts and other			65				29				94
		$	3,559			$	197			$	3,756

		*EksoHealth*				*EksoWorks*				*Total*
Device revenue		$	3,048			$	111			$	3,159
Service and support			644				—				644
Subscriptions			275				7				282
Parts and other			30				7				37
		$	3,997			$	125			$	4,122